Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 1.13% | 163.56 | 0.7% | $1160.35m | |
| PFE | Pfizer Inc. | 0.19% | 36.55 | 0.9% | $1138.06m | |
| LLY | Eli Lilly & Co. | 1.95% | 206.30 | 1.1% | $934.48m | |
| ABBV | AbbVie, Inc. | -0.34% | 110.88 | 1.9% | $732.28m | |
| BMY | Bristol-Myers Squibb Co. | 0.61% | 64.57 | 1.0% | $679.31m | |
| MRK | Merck & Co., Inc. | -0.26% | 80.97 | 0.7% | $677.96m | |
| AZN | AstraZeneca Plc | 1.33% | 53.25 | 1.2% | $669.74m | |
| ARCT | Arcturus Therapeutics Holdings, Inc. | 6.16% | 67.70 | 0.0% | $229.98m | |
| GRTS | Gritstone Oncology, Inc. | 6.11% | 27.11 | 0.0% | $211.05m | |
| VTRS | Viatris, Inc. | 0.69% | 17.43 | 0.0% | $193.56m | |
| RPRX | Royalty Pharma Plc | 1.47% | 51.16 | 0.2% | $174.27m | |
| NVS | Novartis AG | 0.06% | 96.94 | 0.2% | $174.04m | |
| GSK | GlaxoSmithKline Plc | 1.54% | 38.36 | 0.2% | $154.42m | |
| SNY | Sanofi | 0.10% | 49.69 | 0.2% | $134.98m | |
| RGEN | Repligen Corp. | 1.11% | 219.32 | 6.9% | $78.39m |
Company Profile
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.